Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mark Smithers

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
The Lancet. Digital Health|December 18, 2020
Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trialMonika Janda, Caitlin Horsham, Dimitrios Vagenas, et al.
World Journal of Surgery|October 3, 2018
Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS<sup>®</sup>) Society RecommendationsDonald E Low, William Allum, Giovanni De Manzoni, et al.
Journal of the American Academy of Dermatology|September 20, 2023
Automated scoring of tumor-infiltrating lymphocytes informs risk of death from thin melanoma: A nested case-case studySamuel X Tan, Thazin N Aung, Magdalena Claeson, et al.
BMJ Open|November 13, 2019
Evaluation of the efficacy of 3D total-body photography with sequential digital dermoscopy in a high-risk melanoma cohort: protocol for a randomised controlled trialClare Amy Primiero, Aideen M McInerney-Leo, Brigid Betz-Stablein, et al.
Annals of Surgical Oncology|April 4, 2019
The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction AdenocarcinomaSander J M van Hootegem, B Mark Smithers, David C Gotley, et al.
The Journal of Molecular Diagnostics : JMD|August 6, 2023
Circulating Tumor DNA: A Promising Biomarker for Predicting Recurrence in Patients with BRAF-Negative MelanomaLauren G Aoude, Sandra Brosda, Jessica Ng, et al.
Experimental Dermatology|June 16, 2016
GSTP1 does not modify MC1R effects on melanoma riskGemma M Daley, David L Duffy, Annette Pflugfelder, et al.
Plos One|September 23, 2020
Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variantsJenna E Rayner, David L Duffy, Darren J Smit, et al.
Scientific Reports|October 20, 2020
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patientsLauren G Aoude, Vanessa F Bonazzi, Sandra Brosda, et al.
The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
The Lancet. Digital Health|December 18, 2020
Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trialMonika Janda, Caitlin Horsham, Dimitrios Vagenas, et al.
World Journal of Surgery|October 3, 2018
Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS<sup>®</sup>) Society RecommendationsDonald E Low, William Allum, Giovanni De Manzoni, et al.
Journal of the American Academy of Dermatology|September 20, 2023
Automated scoring of tumor-infiltrating lymphocytes informs risk of death from thin melanoma: A nested case-case studySamuel X Tan, Thazin N Aung, Magdalena Claeson, et al.
BMJ Open|November 13, 2019
Evaluation of the efficacy of 3D total-body photography with sequential digital dermoscopy in a high-risk melanoma cohort: protocol for a randomised controlled trialClare Amy Primiero, Aideen M McInerney-Leo, Brigid Betz-Stablein, et al.
Annals of Surgical Oncology|April 4, 2019
The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction AdenocarcinomaSander J M van Hootegem, B Mark Smithers, David C Gotley, et al.
The Journal of Molecular Diagnostics : JMD|August 6, 2023
Circulating Tumor DNA: A Promising Biomarker for Predicting Recurrence in Patients with BRAF-Negative MelanomaLauren G Aoude, Sandra Brosda, Jessica Ng, et al.
Experimental Dermatology|June 16, 2016
GSTP1 does not modify MC1R effects on melanoma riskGemma M Daley, David L Duffy, Annette Pflugfelder, et al.
Plos One|September 23, 2020
Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variantsJenna E Rayner, David L Duffy, Darren J Smit, et al.
Scientific Reports|October 20, 2020
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patientsLauren G Aoude, Vanessa F Bonazzi, Sandra Brosda, et al.
The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.
Pageof 13